Assembly Biosciences, Inc

(NASDAQ:ASMB)

Latest On Assembly Biosciences, Inc (ASMB):

Date/Time Type Description Signal Details
2023-05-04 22:29 ESTNewsAssembly Biosciences GAAP EPS of -$0.37N/A
2023-03-22 23:50 ESTNewsAssembly Biosciences GAAP EPS of -$1.92 in-lineN/A
2022-12-19 15:05 ESTNewsAssembly Biosciences surges 19% on positive data from two trials to treat hepatitis B virusN/A
2022-11-09 02:35 ESTNewsAssembly Biosciences GAAP EPS of -$0.48 beats by $0.06N/A
2022-10-24 18:54 ESTNewsAssembly Biosciences downgraded at Truist on trial failure, lack of catalystsN/A
2022-10-05 18:32 ESTNewsJason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-endN/A
2022-08-09 18:57 ESTNewsAssembly Biosciences GAAP EPS of -$0.51N/A
2022-07-20 18:51 ESTNewsAssembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforceN/A
2022-05-13 07:30 ESTNewsAssembly Biosciences GAAP EPS of -$0.48N/A
2022-03-11 07:35 ESTNewsAssembly Biosciences GAAP EPS of -$3.00 misses by $0.90, revenue of $6.25M beats by $0.09MN/A
2021-11-05 01:28 ESTNewsAssembly Biosciences EPS beats by $0.15N/A
2021-10-20 02:57 ESTNewsAssembly Biosciences and Antios ink clinical collaboration agreementN/A
2021-09-01 19:23 ESTNewsAssembly Bio abandons development of phase 2 hepatitis b candidate; shares down 13%N/A
2021-08-05 22:21 ESTNewsAssembly Biosciences EPS beats by $0.11N/A
2021-08-04 03:06 ESTNewsAssembly Biosciences makes COO and CFO promotionsN/A
2021-07-20 20:00 ESTNewsAssembly Biosciences announces resignation of CFON/A
2021-07-20 19:49 ESTNewsAssembly Bio presents data from HBV core inhibitor programs at EASL 2021N/A
2021-05-07 03:59 ESTNewsAssembly Biosciences EPS beats by $0.10N/A
2021-03-03 15:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $17.6 to $11.6.Neutral
2021-03-02 07:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $17.8 to $17.6.Neutral
2021-03-01 15:07 ESTEarnings EstimateAn EPS average of -$3.32 is estimated for the 2022 year.Sell
2021-03-01 15:07 ESTEarnings EstimateAn EPS average of -$0.76 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-01 15:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $18.6 to $17.8.Neutral
2021-02-28 20:13 ESTNewsAssembly Biosciences, Inc. (ASMB) CEO on Hepatitis B Program Update Call TranscriptN/A
2021-02-26 15:24 ESTNewsAssembly Bio, Arbutus Bio commence trial of triple combo therapy in hepatitis BN/A
2021-02-26 15:07 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 20:03 ESTNewsAssembly Biosciences scraps Phase 3 vebicorvir study plansN/A
2021-02-25 20:03 ESTNewsAssembly Biosciences EPS misses by $0.19, misses on revenueN/A
2020-12-22 11:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $19.2 to $18.6.Neutral
2020-12-13 03:14 ESTFinancialsCompany financials have been released.Neutral
2020-12-08 20:20 ESTNewsAssembly Biosciences pulls the plug on microbiome programN/A
2020-12-07 11:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $22.6 to $19.2.Neutral
2020-11-17 02:37 ESTNewsAssembly Bio inks deal with Door Pharmaceuticals to develop HBV core protein modulatorsN/A
2020-11-15 11:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 03:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 23:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $45.4 to $22.6.Neutral
2020-11-07 03:32 ESTNewsAssembly Bio plunges on disappointing vebicorvir data in HBV infection studyN/A
2020-11-06 11:10 ESTEarnings EstimateAn EPS average of -$0.67 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 02:49 ESTNewsAssembly Biosciences EPS beats by $0.69, beats on revenueN/A
2020-11-01 17:07 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:13 ESTAnalyst RatingThe Analyst Target Price has increased from $43 to $45.4.Buy
2020-09-26 04:19 ESTFinancialsCompany financials have been released.Neutral
2020-09-10 18:35 ESTNewsAssembly Biosciences (ASMB) Investor Presentation - SlideshowN/A
2020-08-28 19:29 ESTNewsAssembly Bio HBV core inhibitors show positive action in studiesN/A
2020-08-28 19:29 ESTNewsAssembly Bio files for $300M mixed shelfN/A
2020-08-27 12:49 ESTNewsAssembly Biosciences teams up with Arbutus Biopharma in chronic HBV infectionN/A
2020-08-15 17:17 ESTNewsStocks To Watch: Walmart, Target, Kandi And Gold vs. BitcoinN/A
2020-08-10 16:47 ESTInsider TradeJohn G McHutchison has directly disposed of 756 shares and currently holds 137,849 shares.Sell
2020-08-10 16:47 ESTInsider TradeJohn G McHutchison has directly disposed of 11,395 shares and currently holds 138,605 shares.Sell
2020-08-07 00:11 ESTFinancialsCompany financials have been released.Neutral

About Assembly Biosciences, Inc (ASMB):

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd.; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California.

ASMB Quotes by TradingView

See Advanced Chart

General

  • Name Assembly Biosciences, Inc
  • Symbol ASMB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 139
  • Last Split Factor1:5
  • Last Split Date2014-07-14
  • Fiscal Year EndDecember
  • IPO Date2010-12-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.assemblybio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 2.17
  • Price/Book (Most Recent Quarter) 0.77
  • Enterprise Value Revenue 5.85
  • Enterprise Value EBITDA 0.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.15
  • Next Year EPS Estimate -$2.88
  • Next Quarter EPS Estimate -$0.76
  • Profit Margin -79%
  • Operating Margin -77%
  • Return on Assets -12%
  • Return on Equity -24%
  • Revenue 79.11 million
  • Earnings Per Share -$3.66
  • Revenue Per Share $2.23
  • Gross Profit -22232000
  • Quarterly Earnings Growth -78.2%
View More

Highlights

  • Market Capitalization 185.11 million
  • EBITDA -99942000
  • Analyst Target Price $11.6
  • Book Value Per Share $7.07
View More

Share Statistics

  • Shares Outstanding 38.25 million
  • Shares Float 33.7 million
  • % Held by Insiders 465%
  • % Held by Institutions 94.26%
  • Shares Short 3.87 million
  • Shares Short Prior Month 2.49 million
  • Short Ratio 2.28
  • Short % of Float 10%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 0.42
  • 52 Week High $27.84
  • 52 Week Low $4.31
  • 50 Day Moving Average 5.55
  • 200 Day Moving Average 9.54
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Assembly Biosciences, Inc (ASMB) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Assembly Biosciences, Inc (ASMB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$1.11-$0.90-22.79%
2020-09-302020-11-05$N/A-$0.09-$0.7888.46%
2020-06-302020-08-05$N/A$0.19$0.22-14.91%
2020-03-312020-05-08$N/A-$0.76-$0.9822.45%
2019-12-312020-03-04$4.77 million-$0.99-$1.011.74%
2019-09-302019-11-07$4.23 million-$0.96-$0.93-3.23%
2019-06-302019-08-05$3.08 million-$0.72-$1.1537.3%
2019-03-312019-05-09$3.89 million-$1.05-$1.061.32%
2018-12-312019-02-28$3.74 million-$1.03-$0.91-13.81%
2018-09-302018-11-08$4.29 million-$0.87-$1.0214.29%
2018-06-302018-08-08$3.22 million-$1.30-$0.88-47.73%
2018-03-312018-05-07$3.57 million-$0.80-$0.76-5.72%
2017-12-312018-03-08$3.32 million-$0.11-$0.8186.36%
2017-09-302017-11-01$2.66 million-$0.71-$0.8819.32%
2017-06-302017-08-09$2.36 million-$0.78-$0.791.27%
2017-03-312017-05-08$684000-$0.81-$0.03-2600%
2016-12-312017-03-02$N/A-$0.67-$0.670%
2016-09-302016-11-09$N/A-$0.67-$0.670%
2016-06-302016-08-09$N/A-$0.59
2016-03-312016-05-11$N/A-$0.64
2015-12-312016-03-11$N/A-$0.45
2015-09-302015-11-09$N/A-$0.38
2015-06-302015-08-13$N/A-$0.41
2015-03-312015-05-08$N/A-$0.64
2014-12-312015-03-12$N/A-$0.38-$0.5733.33%
2014-09-302014-11-17$N/A-$1.33-$0.48-177.08%
2014-06-302014-08-14$N/A-$0.52-$0.6520%
2014-03-312014-04-02$N/A-$1.45-$1.40-3.57%
2013-09-302013-11-12$N/A-$1.25-$1.303.85%
2013-06-302013-08-09$N/A-$1.20-$1.00-20%
2013-03-312013-05-10$N/A-$1.10-$1.100%
2012-12-312013-03-18$N/A-$1.40-$1.549.09%
2012-09-302012-11-13$N/A-$2.05-$1.94-5.67%
2012-06-302012-08-09$N/A-$2.95-$2.89-2.08%
2012-03-312012-05-07$N/A-$3.30-$2.51-31.47%
2011-12-312012-03-14$N/A-$8.90-$5.42-64.21%
2011-09-302011-11-14$N/A-$2.50-$2.500%
2011-06-302011-08-15$N/A-$4.85-$2.55-90.2%
2011-03-312011-05-16$N/A-$1.90-$0.87-118.39%
2010-12-312011-03-02$N/A-$118.00

Assembly Biosciences, Inc (ASMB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Assembly Biosciences, Inc (ASMB) Chart:

Assembly Biosciences, Inc (ASMB) News:

Below you will find a list of latest news for Assembly Biosciences, Inc (ASMB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Assembly Biosciences, Inc (ASMB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest ASMB Trades:

Date Shares Price
Jun 13, 2022 7:48 PM EST22$1.945
Jun 13, 2022 7:48 PM EST28$1.945
Jun 13, 2022 7:49 PM EST100$1.945
Jun 13, 2022 7:52 PM EST100$1.945
Jun 13, 2022 7:53 PM EST100$1.945

Assembly Biosciences, Inc (ASMB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020029795/0001564590-20-029795-index.htm
2020-09-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1426800/000000000020008294/0000000000-20-008294-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000005341719000016/0000053417-19-000016-index.htm
2019-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000005341719000084/0000053417-19-000084-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000005341720000029/0000053417-20-000029-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000021545719003199/0000215457-19-003199-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000083423720004662/0000834237-20-004662-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000090221919000147/0000902219-19-000147-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000090221920000041/0000902219-20-000041-index.htm
2019-04-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000091957419003032/0000919574-19-003032-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000091957420001436/0000919574-20-001436-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000093583619000118/0000935836-19-000118-index.htm
2019-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000093583619000288/0000935836-19-000288-index.htm
2019-12-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000093583619000669/0000935836-19-000669-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000095012319010301/0000950123-19-010301-index.htm
2019-11-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1426800/000095012319010303/0000950123-19-010303-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000108514620000756/0001085146-20-000756-index.htm
2019-01-31SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000113777419000015/0001137774-19-000015-index.htm
2019-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000113777419000061/0001137774-19-000061-index.htm
2019-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000113777419000062/0001137774-19-000062-index.htm
2020-02-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000113777420000021/0001137774-20-000021-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418032466/0001144204-18-032466-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418032468/0001144204-18-032468-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418032469/0001144204-18-032469-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418032470/0001144204-18-032470-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418032472/0001144204-18-032472-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418032474/0001144204-18-032474-index.htm
2018-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420418034900/0001144204-18-034900-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm
2018-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420418037690/0001144204-18-037690-index.htm
2018-07-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1426800/000114420418038336/0001144204-18-038336-index.htm
2018-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420418038525/0001144204-18-038525-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418039137/0001144204-18-039137-index.htm
2018-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420418039140/0001144204-18-039140-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420418042855/0001144204-18-042855-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000114420418042893/0001144204-18-042893-index.htm
2018-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418042894/0001144204-18-042894-index.htm
2018-09-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm
2018-10-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420418053659/0001144204-18-053659-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420418058117/0001144204-18-058117-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000114420418058118/0001144204-18-058118-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418061513/0001144204-18-061513-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418064668/0001144204-18-064668-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418064669/0001144204-18-064669-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420418064671/0001144204-18-064671-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420419011356/0001144204-19-011356-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/0001144204-19-011361-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419017733/0001144204-19-017733-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/0001144204-19-017736-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/0001144204-19-017740-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/0001144204-19-017748-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419017753/0001144204-19-017753-index.htm
2019-04-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419018190/0001144204-19-018190-index.htm
2019-04-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1426800/000114420419018198/0001144204-19-018198-index.htm
2019-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420419020592/0001144204-19-020592-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420419023321/0001144204-19-023321-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420419024898/0001144204-19-024898-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000114420419024904/0001144204-19-024904-index.htm
2019-05-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419024908/0001144204-19-024908-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027155/0001144204-19-027155-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027156/0001144204-19-027156-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027157/0001144204-19-027157-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027158/0001144204-19-027158-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027159/0001144204-19-027159-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027160/0001144204-19-027160-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027161/0001144204-19-027161-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027162/0001144204-19-027162-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420419027502/0001144204-19-027502-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420419037651/0001144204-19-037651-index.htm
2019-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000114420419037687/0001144204-19-037687-index.htm
2019-08-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419037697/0001144204-19-037697-index.htm
2019-08-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419038642/0001144204-19-038642-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/0001144204-19-038644-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000114420419038915/0001144204-19-038915-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000117266119000428/0001172661-19-000428-index.htm
2019-10-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000117266119001984/0001172661-19-001984-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000117266120000736/0001172661-20-000736-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000119312519290108/0001193125-19-290108-index.htm
2019-12-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1426800/000119312519311678/0001193125-19-311678-index.htm
2019-12-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1426800/000119312519313984/0001193125-19-313984-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000119312519315242/0001193125-19-315242-index.htm
2020-08-28S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1426800/000119312520234664/0001193125-20-234664-index.htm
2020-09-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1426800/000119312520238947/0001193125-20-238947-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119051355/0001209191-19-051355-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119051359/0001209191-19-051359-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119051378/0001209191-19-051378-index.htm
2019-10-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119054272/0001209191-19-054272-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119054274/0001209191-19-054274-index.htm
2019-11-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119055720/0001209191-19-055720-index.htm
2019-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119055724/0001209191-19-055724-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919119060715/0001209191-19-060715-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120001149/0001209191-20-001149-index.htm
2020-03-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120021707/0001209191-20-021707-index.htm
2020-03-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120021709/0001209191-20-021709-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/0001209191-20-021796-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120021797/0001209191-20-021797-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm
2020-05-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120032892/0001209191-20-032892-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120032903/0001209191-20-032903-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120036627/0001209191-20-036627-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120036630/0001209191-20-036630-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120036632/0001209191-20-036632-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120036636/0001209191-20-036636-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120036637/0001209191-20-036637-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120036640/0001209191-20-036640-index.htm
2020-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120036642/0001209191-20-036642-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm
2020-10-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120055488/0001209191-20-055488-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1426800/000120919120055491/0001209191-20-055491-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1426800/000149315219001848/0001493152-19-001848-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459019038136/0001564590-19-038136-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459019041796/0001564590-19-041796-index.htm
2020-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020000214/0001564590-20-000214-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020004234/0001564590-20-004234-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020008685/0001564590-20-008685-index.htm
2020-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/0001564590-20-008696-index.htm
2020-04-16PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1426800/000156459020017065/0001564590-20-017065-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1426800/000156459020018818/0001564590-20-018818-index.htm
2020-04-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1426800/000156459020018827/0001564590-20-018827-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020022900/0001564590-20-022900-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000156459020023566/0001564590-20-023566-index.htm
2020-05-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1426800/000156459020026175/0001564590-20-026175-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020029542/0001564590-20-029542-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020029795/0001564590-20-029795-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020032666/0001564590-20-032666-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020036846/0001564590-20-036846-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000156459020036859/0001564590-20-036859-index.htm
2020-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020041552/0001564590-20-041552-index.htm
2020-08-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1426800/000156459020041777/0001564590-20-041777-index.htm
2020-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020047123/0001564590-20-047123-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1426800/000156459020051400/0001564590-20-051400-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1426800/000156459020051470/0001564590-20-051470-index.htm
2018-07-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1426800/000157104918000393/0001571049-18-000393-index.htm
2020-09-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1426800/999999999520002378/9999999995-20-002378-index.htm
2020-02-11SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1426800/999999999720000630/9999999997-20-000630-index.htm
2020-02-26SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1426800/999999999720001013/9999999997-20-001013-index.htm

Assembly Biosciences, Inc (ASMB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Assembly Biosciences, Inc (ASMB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 465%
Institutional Ownership: 9426%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-12-12GRAHAM K COOPEROfficerBuy100,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418064668/0001144204-18-064668-index.htm
2019-08-06John G McHutchisonCEO and PresidentBuy100,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/0001144204-19-038644-index.htm
2018-12-12Jacqueline Sybil PapkoffOfficerBuy10,625.0010,625.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418064671/0001144204-18-064671-index.htm
2018-12-12Richard James ColonnoOfficerBuy20,000.00110,000.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418064669/0001144204-18-064669-index.htm
2019-03-29GRAHAM K COOPEROfficerBuy17,500.00117,500.00https://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/0001144204-19-017736-index.htm
2019-11-06Luisa M StammChief Medical OfficerBuy12,000.0012,000.00https://www.sec.gov/Archives/edgar/data/1426800/000120919119055724/0001209191-19-055724-index.htm
2019-03-29Richard James ColonnoOfficerBuy16,250.00126,250.00https://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/0001144204-19-017740-index.htm
2019-12-12Richard James ColonnoEVP & CSO, Virology OpsSell33,061.0025.00826,577.90127,821.00https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm
2020-03-31Richard James ColonnoEVP & CSO, Virology OpsSell7,812.0015.04117,523.73137,009.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm
2020-08-07John G McHutchisonCEO and PresidentSell756.0022.5017,009.62137,849.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm
2020-08-07John G McHutchisonCEO and PresidentSell11,395.0021.76247,907.34138,605.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm
2020-03-27Richard James ColonnoEVP & CSO, Virology OpsBuy17,000.00144,821.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm
2020-03-27John G McHutchisonCEO and PresidentBuy50,000.00150,000.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/0001209191-20-021796-index.htm
2019-12-12Richard James ColonnoEVP & CSO, Virology OpsBuy33,061.007.03232,418.83160,882.00https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm
2018-06-01WILLIAM R RINGODirectorSell1,000.0042.4742,470.0019,465.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm
2018-07-02WILLIAM R RINGODirectorSell1,000.0038.5038,503.0019,465.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm
2019-10-01Michael P. SamarSVP, Finance and Bus. Ops, PAOBuy2,500.0020,327.00https://www.sec.gov/Archives/edgar/data/1426800/000120919119051378/0001209191-19-051378-index.htm
2018-06-01WILLIAM R RINGODirectorBuy1,000.007.207,200.0020,465.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm
2018-07-02WILLIAM R RINGODirectorBuy1,000.007.207,200.0020,465.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm
2019-12-13Jacqueline Sybil PapkoffSVP-CSO MicrobiomeSell1,460.0021.0030,661.6122,915.00https://www.sec.gov/Archives/edgar/data/1426800/000120919119060715/0001209191-19-060715-index.htm
2019-03-29Jacqueline Sybil PapkoffOfficerBuy13,750.0024,375.00https://www.sec.gov/Archives/edgar/data/1426800/000114420419017753/0001144204-19-017753-index.htm
2020-03-30Jacqueline Sybil PapkoffSVP-CSO MicrobiomeSell1,254.0014.2217,830.8838,661.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm
2020-03-27Jacqueline Sybil PapkoffSVP-CSO MicrobiomeBuy17,000.0039,915.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm
2020-03-27Thomas Joseph RussoCFOBuy43,383.0043,383.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120021797/0001209191-20-021797-index.htm
2020-05-27William E IV DelaneyCSO, VirologyBuy45,000.0045,000.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120032903/0001209191-20-032903-index.htm
2020-03-26Jason A OkazakiChief Legal & Business OfficerBuy50,000.0052,500.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120021709/0001209191-20-021709-index.htm
2018-09-06Uri A LopatinChief Med. Off., VP Res. Dev.Sell336.0040.0113,442.02613,611.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm
2018-09-05Uri A LopatinChief Med. Off., VP Res. Dev.Sell15,204.0040.09609,546.60613,947.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm
2019-03-29Uri A LopatinChief Medical OfficerBuy13,750.00627,361.00https://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/0001144204-19-017748-index.htm
2018-07-20Richard James ColonnoOfficerBuy25,000.0065,000.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418039137/0001144204-18-039137-index.htm
2018-07-19Derek A SmallCEO and PresidentBuy1,200.0041.1949,428.24668,091.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm
2018-07-19Derek A SmallCEO and PresidentBuy1,200.0041.7750,123.04669,291.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm
2019-03-29Derek A SmallCEO and PresidentBuy32,500.00701,791.00https://www.sec.gov/Archives/edgar/data/1426800/000114420419017733/0001144204-19-017733-index.htm
2020-01-02Derek A SmallDirectorBuy125,000.00828,791.00https://www.sec.gov/Archives/edgar/data/1426800/000120919120001149/0001209191-20-001149-index.htm
2018-11-23Richard James ColonnoOfficerBuy25,000.0090,000.00https://www.sec.gov/Archives/edgar/data/1426800/000114420418061513/0001144204-18-061513-index.htm